ArticleRegenerative therapy2026

Monthly multiple injections of leukocyte-poor platelet-rich plasma (ACP®) for knee osteoarthritis: clinical effectiveness across KL grades, dose-response plateau at four, and 24-month durability.

Masahiko KemmochiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.